The earnings call highlighted upcoming product launches and strategic initiatives in robotics and cost management. However, significant revenue and profit declines, along with challenges in key markets and impacts from FDA alerts and tariffs, weigh heavily on performance.

Company Guidance

In the FY2026 Q1 earnings call for Olympus, CEO Bob White outlined several key metrics and strategic initiatives in response to a challenging start to the fiscal year. Consolidated revenue decreased by 12% year-over-year (YoY) to JPY 206.5 billion, with adjusted operating profit dropping 65% YoY to JPY 13.2 billion, reflecting an adjusted operating margin decline of 9.5 points to 6.4%. The US market faced an 18% decline in GIS sales, attributed to tough YoY comparisons and anticipation of new product launches. Olympus aims to drive improvement through new product launches, including the EDOF scopes in the US, and structural cost management to ensure SG&A expenses do not exceed revenue growth. Despite the FDA import alerts and US tariffs effective from August 7, Olympus remains committed to its Elevate quality and regulatory transformation project, which is on track for completion within FY2026. The company is also focusing on innovation, with the establishment of Swan EndoSurgical to accelerate developments in endoluminal robotics, expecting significant contributions from this sector as the market could reach USD 2 billion by 2040. CEO Bob White emphasized the importance of disciplined execution, strategic innovation, and cost efficiency to navigate current challenges and achieve sustainable growth.

Upcoming Product Launches

Olympus anticipates positive momentum in the US from new product launches such as the EDOF scopes, EU-ME3, Slim EBUS scope, VISERA ELITE III, and THUNDERBEAT2. These products are expected to contribute positively to business results.

Strategic Partnership in Robotics

Olympus announced a partnership with Revival Healthcare Capital to create Swan EndoSurgical, aiming to accelerate the development of endoluminal robotics and expand presence in the GI field.

Quality and Regulatory Transformation

Progress in the Elevate project with 96% of quality commitments to the FDA completed, reflecting efforts in patient safety and regulatory compliance.

Focus on Cost Management

Olympus is committed to ensuring SG&A expenses do not exceed revenue growth, aiming for improved execution and cost efficiency through structural reforms.

Olympus (OLYMY) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

OLYMY Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 07, 2025	2026 (Q2)	0.13 / -	0.193	―	―	―
Aug 08, 2025	2026 (Q1)	0.11 / 0.05	0.085	-36.47% (-0.03)
May 13, 2025	2025 (Q4)	0.16 / 0.25	0.078	220.51% (+0.17)
Feb 14, 2025	2025 (Q3)	0.23 / 0.16	0.118	35.59% (+0.04)
Nov 08, 2024	2025 (Q2)	0.21 / 0.19	-0.119	262.18% (+0.31)
Aug 07, 2024	2025 (Q1)	0.09 / 0.09	1.329	-93.60% (-1.24)
May 10, 2024	2024 (Q4)	0.10 / 0.08	0.187	-58.29% (-0.11)
Feb 14, 2024	2024 (Q3)	0.16 / 0.12	0.246	-52.03% (-0.13)
Nov 09, 2023	2024 (Q2)	0.17 / -0.12	0.235	-150.64% (-0.35)
Aug 09, 2023	2024 (Q1)	1.36 / 1.33	0.148	797.97% (+1.18)		―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

OLYMY Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 08, 2025	$12.14	$12.34	+1.65%
May 13, 2025	$13.64	$13.64	0.00%
Feb 14, 2025	$14.94	$14.95	+0.07%
Nov 08, 2024	$17.63	$17.45	-1.02%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Olympus (OLYMY) report earnings?

Olympus (OLYMY) is schdueled to report earning on Nov 07, 2025, TBA (Confirmed).

What is Olympus (OLYMY) earnings time?

Olympus (OLYMY) earnings time is at Nov 07, 2025, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is OLYMY EPS forecast?

OLYMY EPS forecast for the fiscal quarter 2026 (Q2) is 0.13.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing